XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.2
Equity
 6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Equity Equity
As of June 30, 2023 and December 31, 2022, the Company had reserved shares of common stock for issuance in connection with the following:
June 30, 2023December 31, 2022
Options to purchase common stock4,003,501 4,034,287 
Restricted stock units4,529,829 2,807,981 
Shares available for future grant under the 2021 Plan2,646,947 3,151,824 
Shares available for future grant under the ESPP1,572,504 1,179,902 
Total12,752,781 11,173,994 
Preferred Stock
Effective June 14, 2021, in connection with the closing of the Company’s IPO, the Company’s board of directors (“Board”) is authorized to issue up to 10,000,000 shares of preferred stock, $0.01 par value per share, in one or more series. The Company's Board has the discretion to determine the rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges and liquidation preferences, of each series of preferred stock. As of June 30, 2023 and December 31, 2022, no shares of preferred stock were issued or outstanding.
Common Stock
As of June 30, 2023 and December 31, 2022, the Company had authorized 400,000,000 shares of voting common stock, $0.01 par value per share. Each holder of the Company's common stock is entitled to one vote for each share on all matters to be voted upon by the stockholders and there are no cumulative rights. Subject to any preferential rights of any outstanding preferred stock, holders of the Company's common stock are entitled to receive ratably the dividends, if any, as may be declared from time to time by the Board out of legally available funds. If there is a liquidation, dissolution, or winding up of the Company, holders of the Company's common stock would be entitled to share in the Company's assets remaining after the payment of liabilities and any preferential rights of any outstanding preferred stock. The rights, preferences, and privileges of
the holders of the Company's common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock which the Company may designate and issue in the future.